Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
podcast
Podcast
Inside the growing world of biopharma prediction markets
In this episode of “The Top Line,” we explore the growing space of biopharma prediction markets, how they work and the risks they create around insider information and clinical trial integrity.
Will Maddox
,
Ayla Ellison
Sep 18, 2026 9:39am
The future of RAS inhibitors
Sep 11, 2026 9:48am
Novo Nordisk’s CFO on the oral Wegovy rollout and beyond
Aug 7, 2026 8:42am
5 emerging biotech hubs
Jul 17, 2026 9:18am
The deal before the deal
Jun 26, 2026 9:20am
Ipsen R&D chief on pipeline discipline and 2026 milestones
Jun 12, 2026 9:57am